| KDNY Market Cap History Table | ||||||||||||||||||||||||||||
Below is a table of the KDNY market cap history going back to 10/2/2020:
Also see: KDNY Shares Outstanding History and KDNY YTD Return |
KDNY Market Cap History — Chinook Therapeutics Capitalization Over Time
As of 8/4/2023 Chinook Therapeutics has a market cap of 2.89 billion. Investors often follow the KDNY market cap history to compare the size of the company over time.
This page shows KDNY market capitalization trends over time, with 13 market cap datapoints presented, dating back to 10/2/2020.
| KDNY Market Cap History Chart | |||||||||||||||||||||||||||||
KDNY Historical Market Cap: +145.08% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||
| KDNY Stock Price Chart |
| About Chinook Therapeutics Inc |
| Chinook Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing precision medicines for kidney diseases. Co.'s pipeline is focused on kidney diseases with clinical pathways. Co.'s lead clinical program is atrasentan, an endothelin A receptor antagonist. Co.'s second product candidate, BION-1301, is an anti-APRIL monoclonal antibody also in development for patients with IgA nephropathy. Co. developing CHK-336 for the treatment of primary hyperoxaluria as well as secondary hyperoxaluria and idiopathic kidney stone formation. Co. is also conducting research programs in several other rare, severe chronic kidney diseases. We show 13 historical shares outstanding datapoints in our KDNY shares outstanding history coverage, used to compute KDNY market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KDNY market cap history over the course of time is important for investors interested in comparing KDNY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KDNY versus a peer is one thing; comparing KDNY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KDNY can fluctuate over the course of history. With this page we aim to empower investors researching KDNY by allowing them to research the KDNY market cap history. |
| KDNY Current Stock Quote |
Quotes delayed 20 minutes  Free KDNY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| KDNY Share Performance |
| Market Cap Peers |
| Chinook Therapeutics (KDNY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
KEQU Market Cap History KERX Market Cap History KIDS Market Cap History KIN Market Cap History KLDO Market Cap History KLRS Market Cap History KMPH Market Cap History KND Market Cap History KNTE Market Cap History KOD Market Cap History More Healthcare companies » |
KDNY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
